NRG
TMO icon

Nemes Rush Group’s Thermo Fisher Scientific TMO Stock Holding History

Nemes Rush Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.51K Sell
9
-5
-36% -$2.4K ﹤0.01% 681
2026
Q1 		$6.88K Buy
14
+7
+100% +$3.8K ﹤0.01% 596
2025
Q4 		$4.06K Buy
+7
New +$3.96K ﹤0.01% 653
2025
Q3 		– Sell
-7
Closed -$2.84K – 740
2025
Q2 		$2.84K Buy
7
+1
+17% +$418 ﹤0.01% 582
2025
Q1 		$2.99K Hold
6
– – ﹤0.01% 579
2024
Q4 		$3.12K Buy
+6
New +$3.3K ﹤0.01% 583

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Nemes Rush Group's TMO Position: Q2 2026 in Review

Nemes Rush Group reduced its Thermo Fisher Scientific (TMO) stake by 36% in Q2 2026, selling an estimated $2.4K and leaving 9 shares worth $4.51K. The position accounts for ﹤0.01% of the portfolio, ranked #681.

Nemes Rush Group first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.88K in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Nemes Rush Group held 9 shares of Thermo Fisher Scientific worth $4.51K as of Q2 2026.
  • Nemes Rush Group sold 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
  • Thermo Fisher Scientific made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #681 holding.
  • Nemes Rush Group first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Nemes Rush Group's Thermo Fisher Scientific position peaked at $6.88K in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.